Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Comparison of delayed imaging with Tc-99m PMT and Tc-99m DEIDA for visualization of hepatoma

Journal Article · · Clinical Nuclear Medicine; (USA)
Delayed imaging was performed after the intravenous administration of Tc-99m DEIDA and Tc-99m PMT in 18 patients with hepatocellular carcinoma. Using Tc-99m DEIDA imaging, sharp uptake by liver tumors was observed in four patients (22%), but the uptake was similar to that of the surrounding normal liver in eight patients (44%). Using Tc-99m PMT imaging, the uptake by the tumor was notable in ten patients (56%) and normal in two (11%). Tc-99m PMT and Tc-99m DEIDA were both concentrated in hepatocellular carcinomas, but the former showed intense uptakes more frequently, and thus is suggested to be useful in the diagnosis of hepatocellular carcinoma.
OSTI ID:
5411545
Journal Information:
Clinical Nuclear Medicine; (USA), Journal Name: Clinical Nuclear Medicine; (USA) Vol. 14:7; ISSN CNMED; ISSN 0363-9762
Country of Publication:
United States
Language:
English